top of page
Group 15 (2).png


The State of FemTech 2021-2022: Industry Review and Outlook

27 January 2022 (5:00 - 6:30 PM GMT)

Facebook 1920x1080 (2).png

“The State of FemTech 2021-2022: Industry Review and Outlook” is a free virtual event combining speaker’s talks and the panel discussion on what to expect in women’s health and FemTech in 2022.

During the conference, each panelist will conduct a 10 minute talk followed by a joint panel discussion from the moderator and the audience.


unnamed (4).jpg

Laina Latterner

Strategic Sales and Marketing Consultant

Laina Latterner is an accomplished, strategic sales and marketing consultant with over 15 years of experience in the global medical device industry with organizations including Roche Diagnostics and McKesson. 

Her critical thinking and innovative ideas combined with her deep knowledge of laboratory testing, women’s health, and healthcare reform, enable her to identify unique opportunities in the marketplace for her clients. 

She is passionate about working towards health equity and improving women’s health globally. 

  • LinkedIn


Kate B.png

Kate Batz

Director, FemTech Analytics

Kate Batz is Director of FemTech Analytics and Managing Partner of Longevity.Capital, a specialized investment fund focused on the Longevity Industry. She is also Director of Strategy and Business Development at Deep Knowledge Ventures Group, comprising of Deep Knowledge Ventures, Aging Analytics Agency, and Deep Knowledge Analytics. Kate is an experienced corporate attorney by background, licensed to practice law in California, New York, and Russia, with extensive sales and marketing experience. 

At the beginning of her career, Kate was involved with international litigation when she worked for a former Pennsylvania state senator. As a corporate attorney, Kate worked with many Fortune 500 clients. Сompelled by the paradigm-shifting advances in science and technology in the fields of aging and Longevity, Kate joined Deep Knowledge Ventures Group. Kate is based in San Francisco, California.

  • LinkedIn

Michelle Egger

Co-Founder & CEO, BIOMILQ

As a passionate food scientist, Michelle looks to combat global food security and malnutrition in everything she does. She has expertise in dairy fermentation, formulation, and processing and is thrilled to ditch the cows for humans. Inspired by upstream solutions for infant nutrition at the Bill and Melinda Gates Foundation, she became obsessed with advancing human nutrition through better infant feeding options. Michelle seeks to harness the capacity to drive environmental and social change through creative food solutions with a consumer-first design. Her entrepreneurial expertise in social impact and sustainable business models drives her commitment to seeking mission-aligned partners.

  • LinkedIn
Susan Trent.png

Susan Trent

CEO, Atlantic Therapeutics

Susan has enjoyed a 20+ year career in GSK Pharmaceuticals and Consumer Healthcare, with extensive International experience gained in the UK, Latin America, Japan, SE Asia and USA. She has held GM, marketing, sales, business development and strategic planning roles at an operational and above-country level. She has proved adept at delivering results in diverse environments through strong relationship-building at all organizational levels.


Throughout her career, Susan’s particular area of focus has been in building brands that leverage strong science to meet a clear unmet consumer need. In her most recent role pre-AT, she created a new consumer brand in prostate health for a nutraceutical company, successfully launching it in the US via direct-to-consumer ecommerce and medical endorsement. Immediately prior, she ran GSK’s newly acquired Skin Health portfolio, taking traditionally hcp-focused brands and successfully bringing them into the consumer marketplace with compelling communications campaigns and appropriate commercial strategies.

  • LinkedIn
Dr. Samantha Lattof.png

Dr. Samantha Lattof

CEO and Co-Founder of Maila Health

As CEO and Co-Founder of Maila Health, Dr. Samantha Lattof works to improve maternal and newborn health by bridging research and technology.

Dr. Lattof has over fifteen years of experience conducting womxn’s health research and driving global health programs and projects. Her research has been used to develop health guidelines and inform policy. She has consulted for the World Health Organization’s Network for Improving Quality of Care for Maternal, Newborn and Child Health; Ipas; and LSE Enterprise. Prior to consulting, she worked for the London School of Economics and Political Science, Harvard School of Public Health, and Columbia University.

Dr. Lattof earned her PhD at the London School of Economics and Political Science and her Master of Science at Harvard School of Public Health.

  • LinkedIn
Copy of Terri H.png

Terri Harris

Head of Media, FemTech Lab

Terri Harris is the Head of Media for FemTech.Live, the largest FemTech-focused media site, as well as supporting the first FemTech-focused accelerator FemTech Lab. Through her work with both FemTech.Live and FemTech Lab Terri has her finger on the pulse when it comes to FemTech, staying ahead of the latest trends and investments. 

Terri is also a Sexual and Reproductive Health educator who has worked in the Middle East, East Africa and the UK supporting women, girls and people who menstruate to be more conscious of their bodies and the power they hold.

  • LinkedIn
Dr Michelle Perugini.png

Dr. Michelle Perugini

CEO & Co-Founder at Presagen

Dr. Michelle Perugini is a health tech entrepreneur with extensive experience in healthcare and advanced AI technologies. Michelle is an avid supporter of the AI and women’s health sectors globally, and Winner of the 2021 Women in AI (WAI) Healthcare Award. She has a PhD in Medicine and was a post-doctoral research fellow in Oncology for a decade. She has founded 2 global AI tech companies, the first of which was acquired by EY in 2015. Michelle is currently Co-Founder and CEO of Presagen, an AI healthcare company building The Social Network for Healthcare, with a focus in Women’s Health. Presagen’s first product Life Whisperer uses AI for embryo selection to improve pregnancy outcomes in IVF, and is being used in IVF clinics globally.

“Women’s Health is not niche, it’s just different! How AI can play a role in improving outcomes at global scale.”

  • LinkedIn



(5 mins)

Opening Remarks

Kate Batz (Director, FemTech Analytics)
Laina Latterner (Strategic Sales and Marketing Consultant)


(10 mins)

“A Direct-to-Consumer Approach to Tackling a Taboo Topic”

Susan Trent (CEO, Atlantic Therapeutics)


(10 mins)

“Prioritizing Values in Venture Capital”

Michelle Egger (Co-Founder & CEO, BIOMILQ)


(10 mins)

“Advancing FemTech by Embracing Privacy and Data Security”

Dr. Samantha Lattof (CEO and Co-Founder, Maila Health)


(10 mins)

 “FemTech the Revolution: More than Digital Health for Women”

Terri Harris (Head of Media, FemTech Lab)


(10 mins)

“Women’s Health is not niche, it’s just different!
How AI can play a role in improving outcomes at global scale” 

Dr. Michelle Perugini (CEO & Co-Founder, Presagen)


(10 mins)

“Key Trends to Watch in FemTech in 2022”

Kate Batz (Director, FemTech Analytics) 


(20 mins)

Panel Discussion



(5 mins)

Closing Remarks

Laina Latterner (Strategic Sales and Marketing Consultant)

The State of FemTech 2021-2022: Industry Review and Outlook

27 January 2022 (5:00 - 6:30 PM GMT)

Previous Events

The Rise of Advanced Technologies in the Pharmaceutical Industry (Facebook).png

"Raising Capital in FemTech: Opportunities and Challenges" is a free virtual event combining speaker's talks and the roundtable discussion on crucial investments topics. The lack of investments is a fundamental challenge for FemTech companies.


Investors and FemTech founders will share their insights and best practices, and answer all your questions about raising capital in the space.

Femtech Conference 1920x1080.png

“FemTech Advancing Women's Wellness and Lifespan” was a virtual 1-day conference featuring a number of FemTech influencers, including founders & CEOs of startups and established companies, investors, scientists and other key players in the Women's Health industry.

The event was focus on the impact of technologies on women’s health and lifespan and how FemTech contributes to women’s Longevity in general.

Femtech Conference 1920x1080 (1)-min.png

The virtual conference "FemTech Industry Landscape 2021: Discovering New Horizons" held on July 29, 2021, where professionals from FemTech Analytics and invited guest speakers who are Founders & CEO of FemTech companies and start-ups, Healthcare Innovators, Investors and Hubs, Women Influencers and Enthusiasts shared insights, findings and personal experience about new possibilities and cutting-edge technologies in fast developing FemTech market.

bottom of page